Ilesanmi, A.; Stevens-Washington, C.; Jones, S.; Alarcon, K.; Aryal, A.; Subbarayalu, P.; Shackleford, T.J.; Crossley, D.; Onyeagucha, B.C.
Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy. Therapeutics 2026, 3, 5.
https://doi.org/10.3390/therapeutics3010005
AMA Style
Ilesanmi A, Stevens-Washington C, Jones S, Alarcon K, Aryal A, Subbarayalu P, Shackleford TJ, Crossley D, Onyeagucha BC.
Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy. Therapeutics. 2026; 3(1):5.
https://doi.org/10.3390/therapeutics3010005
Chicago/Turabian Style
Ilesanmi, Ayooluwa, Casey Stevens-Washington, Shelby Jones, Karina Alarcon, Anush Aryal, Panneerdoss Subbarayalu, Terry J. Shackleford, Davida Crossley, and Benjamin C. Onyeagucha.
2026. "Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy" Therapeutics 3, no. 1: 5.
https://doi.org/10.3390/therapeutics3010005
APA Style
Ilesanmi, A., Stevens-Washington, C., Jones, S., Alarcon, K., Aryal, A., Subbarayalu, P., Shackleford, T. J., Crossley, D., & Onyeagucha, B. C.
(2026). Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy. Therapeutics, 3(1), 5.
https://doi.org/10.3390/therapeutics3010005
